MAPK8 and colorectal carcinoma: The results showed that ILL (3–9 μM) dose-dependently inhibited the proliferation and colony formation of OXA-sensitive and CRC cells through activation of JNK/p38 MAPK signaling, and induced G2/M phase arrest, ROS accumulation, and apoptosis.